This Crispr Therapeutics Stock: Why It Fell Today So Far
Biotech investors woke up to a sharp move in this crispr therapeutics stock after CRISPR Therapeutics announced new d...
Combining total market funds with international funds in retirement can create a diversified, tax-efficient portfolio with smoother growth.
28,507 articlesBiotech investors woke up to a sharp move in this crispr therapeutics stock after CRISPR Therapeutics announced new d...
ETH activity climbs to record levels in Q1 2026 even as price declines and fees shrink. Analysts call it a classic re...
As GTC 2026 nears, Nvidia, Broadcom, and Coherent gear up for major AI hardware unveilings. Analysts see potential fo...
A breakthrough budget EV pickup priced at $24,950 hits the market, backed by high-profile investors. Analysts questio...
mastec (mtz) 150% year momentum drives the rally as the company backs a strong 2026 outlook. Analysts see upside as b...
A recent sale of 25,000 ALHC shares by Alignment Healthcare’s vice chairman has investors wondering about the stock’s...
Navitas Semiconductor is pursuing an AI data-center power strategy built around 800V architecture. This move could re...
Nebius stock falls 17% after revealing a ballooning debt load, undersc9oring how the neocloud trade could turn into a...
CrossCountry Mortgage enters the race to acquire Two Harbors, joining a competing all cash bid and heightening a batt...
A surge in Lemonade's stock grabbed attention as investors weighed renewed reinsurance terms and AI-driven growth. Th...
Insider moves can reveal much about a company’s outlook, but they aren’t a single data point. This article breaks dow...
Off the field, Haaland maps a broader financial playbook, backing chess events, an investment firm, and a film role a...